OREANDA-NEWS. On 25 May 2009 was announced, that ZAO “Apteki 36.6” and OJSC Valenta signed an agreement on direct collaboration. Under the terms in the contract medicines produced by Valenta will be delivered directly to Pharmacy Chain 36.6.

As a result of this cooperation, the final prices to 36.6 customers on Valenta products are expected to be lowered by 4—9 % depending on the category of the product.

Besides the innovative original preparations — Ingavirin, Zydena, Trimedat, Teralidgen, which have entered the market this year will be presented in all 36.6 pharmacies.

Pharmacy Chain 36.6 will supply the goods upon the agreement through its own logistic system.

Ruslan Vorobel, Commercial Director for Pharmacy Chain 36.6 “We continue to make progress in signing direct Agreements with manufactures and reducing our retail prices. We are pleased that our direct supply initiative was supported by Valenta, one of the largest domestic manufacturerers in the Russian pharmaceutical market. We are confident that this successful experience of direct contracts with large domestic manufacturers will become the jump-start for many foreign manufacturers to approach positively to optimization of existing interaction schemes. It is our strategic aim to work directly with 100 % of manufacturers either through direct supplies, thereby reducing distribution costs, or cooperation in marketing, when we grant manufacturers additional possibilities on promotion of their goods in our pharmacies".

Dr. Laszlo Sugar, CEO at Valenta Pharm “We are sincerely glad to such constructive cooperation with Pharmacy Chain 36.6. We share a policy of the 36.6 company during a global economic crisis and are pleased that we can bring our medical products directly to the consumer".